Institution statistics

NOVO NORDISK A/S - Denmark 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:700-800
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:500-600
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:900-1000
Total Number of Projects:69
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:600-700
Project Leadership Index:600-700
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:700-800
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:600-700
Total Number of Projects:> 1000
Total Project Funding:600-700
Networking Rank (Reputation):> 1000
Partner Constancy:800-900
Project Leadership Index:500-600
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:700-800
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:600-700
Project Leadership Index:600-700
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 37
As coordinator: 1
As participant: 36
Sole participant: 0
Coordinator / Participant Ratio: 0.03*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 22.458.244 300.000 3
2019 0 40.904.592 0 4
2018 0 25.821.795 290.082 5
2017 0 31.347.714 0 3
2016 0 26.949.452 580.164 3
2015 0 20.276.334 290.082 2
2012 0 8.316.954 912.873 2
2010 0 3.199.995 0 1
2009 0 8.073.000 733.909 1
2008 7.099.992 11.400.000 1.258.653 1 1
2007 0 3.000.000 375.000 1
2006 0 19.423.320 786.912 3
2005 0 49.896.204 1.926.580 5
2004 0 22.700.000 845.788 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE12
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD11
UNIVERSITY OF COPENHAGEN11
ELI LILLY AND COMPANY LIMITED10
NOVARTIS PHARMA10
PFIZER LIMITED10
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT9
JANSSEN PHARMACEUTICA NV9
KATHOLIEKE UNIVERSITEIT LEUVEN8
SANOFIAVENTIS DEUTSCHLAND8
KAROLINSKA INSTITUTE7
LUNDS UNIVERSITET7
KING'S COLLEGE LONDON6
UCB BIOPHARMA6
UNIVERSITY OF DUNDEE6
ACADEMISCH ZIEKENHUIS GRONINGEN5
REGION HOVEDSTADEN5
STICHTING KATHOLIEKE UNIVERSITEIT5
UNIVERSITE DE LAUSANNE5
UNIVERSITE LIBRE DE BRUXELLES5
UPPSALA UNIVERSITET5
ABBVIE INC4
ACADEMISCH ZIEKENHUIS LEIDEN4
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE4
EUROPEAN PATIENTS' FORUM4
F HOFFMANNLA ROCHE4
H LUNDBECK AS4
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER4
JDRF INTERNATIONAL4
MERCK SHARP & DOHME CORP4
SANOFIAVENTIS4
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE4
UNIVERSITY OF HELSINKI4
ASTRAZENECA AB3
BAYER AKTIENGESELLSCHAFT3
BAYER PHARMA3
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG3
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3
CHARITE UNIVERSITAETSMEDIZIN BERLIN3
CHARLES UNIVERSITY IN PRAGUE THIRD FACULTY OF MEDICINE3
EBERHARD KARLS UNIVERSITAET TUEBINGEN3
EUROPEAN MOLECULAR BIOLOGY LABORATORY3
KUNGLIGA TEKNISKA HOEGSKOLAN3
LUND UNIVERSITY3
MEDICAL RESEARCH COUNCIL3
MEDIZINISCHE UNIVERSITAET WIEN3
MEDIZINISCHE UNIVERSITAT GRAZ3
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN3
SIB INSTITUT SUISSE DE BIOINFORMATIQUE3
STICHTING VUMC3
TAKEDA DEVELOPMENT CENTRE EUROPE3
TECHNISCHE UNIVERSITAET DRESDEN3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE3
THE LEONA M AND HARRY B HELMSLEY CHARITABLE TRUST3
THE UNIVERSITY OF MANCHESTER3
THE UNIVERSITY OF SHEFFIELD3
UNIVERSITA DEGLI STUDI DI MILANO3
UNIVERSITA DEGLI STUDI DI PADOVA3
UNIVERSITA DI PISA3
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT3
UNIVERSITY COLLEGE LONDON3
UNIVERSITY OF LEEDS3
UNIVERSITY OF TURKU3
UNIVERSITY OF WALES CARDIFF3
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ALLERGAN LIMITED2
ANTAROS MEDICAL AB2
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
BAYER2
BRISTOLMYERS SQUIBB COMPANY CORP2
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE2
CENTRE HOSPITALIER DE LUXEMBOURG2
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER2
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE2
CHRISTIAN DE DUVE INSTITUTE OF CELLULAR PATHOLOGY2
COVANCE LABORATORIES2
DANMARKS TEKNISKE UNIVERSITET2
DIGILAB BIOVISION2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
ELLEGAARD GOTTINGEN MINIPIGS AS2
EUROPEAN AIDS TREATMENT GROUP EV2
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
FUJIFILM CELLULAR DYNAMICS INC2
GENFIT2
GENOME RESEARCH2
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT2
HANNOVERSCHE KINDERHEILANSTALT2
INSTITUT DE RECHERCHES SERVIER2
INSTITUT KLINICKE A EXPERIMENTALNI MEDICINY2
ITASUOMEN YLIOPISTO2
JOHANN WOLFGANG GOETHEUNIVERSITATFRANKFURT AM MAIN2
KOBENHAVNS UNIVERSITET2
LIPOTYPE2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
MERCK KGAA2
OSLO UNIVERSITETSSYKEHUS HF2
OSPEDALE PEDIATRICO BAMBINO GESU2
Constancy:

Total number of partners:841

Partner loyalty:
Frequent Partner: (> 2 projects): 305
Rare Partner: 536

Frequent / Rare Partner Ratio: 0.57

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES13
RTD HORIZONTAL TOPICS8
INDUSTRY AND TECHNOLOGY4
SOCIAL AND ECONOMIC CONCERNS3

Project overview:

Start dateProjectacronymrolefundingpartners
2020-05-01Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA INNODIA HARVESTparticipant5.999.05540
2020-01-01Novel Strategies for Cell-based Neural Reconstruction NSC-Reconstructparticipant8.168.49513
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69428
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLparticipant12.004.95336
2019-04-01Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation ConcePTIONparticipant15.299.99153
2019-03-01EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells EBiSC2participant4.599.64816
2019-01-01Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain IM2PACTparticipant9.000.00027
2018-09-01Ensuring the future of EUPATI beyond 2020 EFOEUPATIparticipant365.24312
2018-09-01PET Imaging of Alpha-Synuclein Fibril Formation PET-AlphaSyparticipant4.100.37016
2018-05-01Hypoglycaemia - REdefining SOLutions for better liVEs Hypo-RESOLVEparticipant13.450.05723
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93134
2018-01-01European Research Training to Decipher The Ub Code : identification of potential biomarkers and drug targets UbiCODEparticipant3.407.19420
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 IB4SD-TRISTANparticipant12.000.00021
2016-09-01Unraveling Principles of PDZ-mediated Cell Signaling PDZnetparticipant3.733.51510
2016-09-01Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 BEAt-DKDparticipant15.085.93731
2016-04-01Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881 RHAPSODYparticipant8.130.00027
2015-11-01Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797 INNODIAparticipant17.630.00036
2015-01-01Multi-Stimuli Responsive Molecular Systems and Materials ResMoSysparticipant2.646.3349
2012-09-01A Portable bihormonal Closed Loop for Diabetes PCDIABparticipant4.335.2847
2012-01-01European Training Network for Excellence in Molecular Imaging in Diabetes BetaTrainparticipant3.981.67010
2010-10-01Intelligent and Customized Tooling IC2participant3.199.99516
2009-07-01In Vivo Imaging of Beta cell Receptors by Applied Nano Technology VIBRANTparticipant8.073.00011
2008-03-01Personal Glucose Predictive Diabetes Advisor DIAdvisorcoordinator7.099.99213
2008-01-01Metagenomics of the human intestinal tract METAHITparticipant11.400.00016
2007-01-01Functional Genomic diagnostic tools for coronary artery disease FGENTCARDparticipant3.000.0008
2006-10-01An examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes INTERACTparticipant10.000.00032
2006-10-01Nanoscale Functionalities for Targeted Drug Delivery of Biopharmaceutics NANOBIOPHARMACEUTICSparticipant7.997.72027
2006-02-01Total Crystallography: Structure and dynamics of polycrystals TOTALCRYSTparticipant1.425.6008
2005-12-01The Identification of Risk Factors for the Development of Diabetic Nephropathy: The PREDICTIONS Project PREDICTIONSparticipant1.757.50010
2005-11-01Hepatic and adipose tissue and functions in the metabolic syndrome HEPADIPparticipant11.656.80024
2005-10-01Innovative medicines for europe INNOMEDparticipant11.998.52742
2005-04-01Beta cell programming for treatment of diabetes BETACELLTHERAPYparticipant11.788.00024
2005-01-01Health benefits of exercise: identification of genes and signalling pathways involved in effects of exercise on insulin resistance, obesity and the metabolic syndrome EXGENESISparticipant12.695.37726
2004-12-01Biosimulation - A New Tool in Drug Development BIOSIMparticipant10.700.00039
2004-10-01Molecular phenotyping to accelerate genomic epidemiology MOLPAGEparticipant12.000.00021

Alias institution names:
  • NOVO NORDISK

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum